Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashant Khare

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Nature Immunology|June 21, 2016
Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitinationMahesh Kathania, Prashant Khare, Minghui Zeng, et al.
Parasitology|December 16, 2014
Immunological consequences of stress-related proteins--cytosolic tryparedoxin peroxidase and chaperonin TCP20--identified in splenic amastigotes of Leishmania donovani as Th1 stimulatory, in experimental visceral leishmaniasisAnil Kumar Jaiswal, Prashant Khare, Sumit Joshi, et al.
Vaccine|September 3, 2008
Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasisShraddha Kumari, Mukesh Samant, Pragya Misra, et al.
Journal of Vector Borne Diseases|October 7, 2024
Serotypic and genotypic profile of dengue virus outbreaks in India between 2011 and 2017Ashvini Kumar Yadav, Divya Namdeo, Prashant Khare, et al.
Parasitology Research|December 28, 2013
Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasisPrashant Khare, Anil Kumar Jaiswal, Chandra Dev Pati Tripathi, et al.
Expert Opinion on Drug Delivery|March 11, 2014
Development of targeted 1,2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improved in vitro and in vivo effect in leishmaniasisRenuka Khatik, Pankaj Dwivedi, Prashant Khare, et al.
Nature Communications|October 31, 2018
SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2Amir Kumar Singh, Prashant Khare, Abeer Obaid, et al.
International Journal for Parasitology. Drugs and Drug Resistance|May 17, 2016
Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin BSanketkumar Pandya, Rahul Kumar Verma, Prashant Khare, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2009
Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasisMukesh Samant, Reema Gupta, Shraddha Kumari, et al.
Plos One|October 11, 2012
Leishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasisPramod K Kushawaha, Reema Gupta, Chandra Dev Pati Tripathi, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Nature Immunology|June 21, 2016
Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitinationMahesh Kathania, Prashant Khare, Minghui Zeng, et al.
Parasitology|December 16, 2014
Immunological consequences of stress-related proteins--cytosolic tryparedoxin peroxidase and chaperonin TCP20--identified in splenic amastigotes of Leishmania donovani as Th1 stimulatory, in experimental visceral leishmaniasisAnil Kumar Jaiswal, Prashant Khare, Sumit Joshi, et al.
Vaccine|September 3, 2008
Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasisShraddha Kumari, Mukesh Samant, Pragya Misra, et al.
Journal of Vector Borne Diseases|October 7, 2024
Serotypic and genotypic profile of dengue virus outbreaks in India between 2011 and 2017Ashvini Kumar Yadav, Divya Namdeo, Prashant Khare, et al.
Parasitology Research|December 28, 2013
Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasisPrashant Khare, Anil Kumar Jaiswal, Chandra Dev Pati Tripathi, et al.
Expert Opinion on Drug Delivery|March 11, 2014
Development of targeted 1,2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improved in vitro and in vivo effect in leishmaniasisRenuka Khatik, Pankaj Dwivedi, Prashant Khare, et al.
Nature Communications|October 31, 2018
SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2Amir Kumar Singh, Prashant Khare, Abeer Obaid, et al.
International Journal for Parasitology. Drugs and Drug Resistance|May 17, 2016
Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin BSanketkumar Pandya, Rahul Kumar Verma, Prashant Khare, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2009
Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasisMukesh Samant, Reema Gupta, Shraddha Kumari, et al.
Plos One|October 11, 2012
Leishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasisPramod K Kushawaha, Reema Gupta, Chandra Dev Pati Tripathi, et al.
Pageof 4